Amoxapine
Spezifikationen
14028-44-5CAS-Nummer
237-867-1EG-Nummer
8-chloro-6-piperazin-1-ylbenzo[b][1,4]benzoxazepineIUPAC-Name
C17H16ClN3OChemische Formel
313.8 g/molMolekulargewicht
amoxapine; 14028-44-5; Asendin; Demolox; Amoxan; Desmethylloxapin; Amoxapina; Asendis; Amoxapinum; CL 67772; CL-67772; Dibenz[b,f][1,4]oxazepine, 2-chloro-11-(1-piperazinyl)-; 2-Chloro-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepine; DTXSID7022598; 2-Chloro-11-(1-piperazinyl)dibenz[b,f][1,4]oxazepine; CL 67,772; CL-67,772; NSC-759559; R63VQ857OT; Desmethylloxapine; DIBENZ(b,f)(1,4)OXAZEPINE, 2-CHLORO-11-(1-PIPERAZINYL)-; 2-chloro-11-(piperazin-1-yl)dibenzo[b,f][1,4]oxazepine; CHEBI:2675; DTXCID102598; Defanyl; 13-chloro-10-(piperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene; 8-chloro-6-piperazin-1-ylbenzo(b)(1,5)benzoxazepine; 8-chloro-6-piperazin-1-ylbenzo[b][1,5]benzoxazepine; 2-Chloro-11-(piperazin-1-yl)dibenzo(b,f)(1,4)oxazepine; 13-chloro-10-(piperazin-1-yl)-2-oxa-9-azatricyclo(9.4.0.0^(3,8))pentadeca-1(11),3(8),4,6,9,12,14-heptaene; CL67,772; RefChem:58242; N06AA17; 13-chloro-10-(piperazin-1-yl)-2-oxa-9-azatricyclo(9.4.0.03,8)pentadeca-1(11),3,5,7,9,12,14-heptaene; 237-867-1; Moxadil; Amoxepine; 8-chloro-6-piperazin-1-ylbenzo[b][1,4]benzoxazepine; MFCD00069210; CHEMBL1113; MLS000069371; 2-chloro-11-piperazin-1-yldibenzo[b,f][1,4]oxazepine; 8-chloro-6-piperazin-1-yl-benzo[b][1,4]benzoxazepine; NCGC00015004-09; Ascendin; SMR000058416; CAS-14028-44-5; Amoxapinum [INN-Latin]; Amoxapina [INN-Spanish]; Asendin (TN); SR-01000003001; EINECS 237-867-1; amoxipine; BRN 0832057; UNII-R63VQ857OT; 2-Chlor-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepin; Prestwick_503; Amoxapine (Standard); Amoxapine [USAN:USP:INN:BAN:JAN]; KS-1197; Opera_ID_33; LOXAPINE_met006; Spectrum_000446; CPD000058416; AMOXAPINE [INN]; AMOXAPINE [JAN]; AMOXAPINE [MI]; Lopac-A-129; AMOXAPINE [USAN]; Prestwick0_000102; Prestwick1_000102; Prestwick2_000102; Prestwick3_000102; Spectrum2_001245; Spectrum3_001067; Spectrum4_001218; Spectrum5_001284; AMOXAPINE [VANDF]; A-129; AMOXAPINE [MART.]; AMOXAPINE [USP-RS]; AMOXAPINE [WHO-DD]; Lopac0_000116; REGID_for_CID_2170; SCHEMBL33950; BSPBio_000084; BSPBio_002654; GTPL201; KBioGR_001656; KBioSS_000926; DivK1c_000236; SPECTRUM2300161; Amoxapine - Bio-X trade mark; SPBio_001150; SPBio_002023; Amoxapine (JP18/USP/INN); Amoxapine, 1mg/ml in Methanol; BPBio1_000094; orb1226355; orb1308148; AMOXAPINE [ORANGE BOOK]; 2-Chloro-11-(1-piperazinyl)dibenzo[b,f][1,4]oxazepine; AMOXAPINE [USP IMPURITY]; SCHEMBL29354942; SCHEMBL29370074; SCHEMBL29482386; BDBM22870; HMS500L18; HY-B0991R; KBio1_000236; KBio2_000926; KBio2_003494; KBio2_006062; KBio3_001874; AMOXAPINE [USP MONOGRAPH]; NINDS_000236; GLXC-07439; HMS1568E06; HMS2089G10; HMS2093N08; HMS2095E06; HMS2231E13; HMS3259G08; HMS3260G14; HMS3370P03; HMS3712E06; HMS5087G18; Pharmakon1600-02300161; HY-B0991; MSK10881; Tox21_110064; Tox21_302352; Tox21_500116; CCG-39135; EBC-06994; NSC759559; PDSP1_001609; PDSP2_001593; s4218; AKOS015895092; Tox21_110064_1; AC-5495; CS-4485; DB00543; FA17884; LP00116; NC00546; NSC 759559; SDCCGSBI-0050104.P004; IDI1_000236; NCGC00015004-01; NCGC00015004-02; NCGC00015004-03; NCGC00015004-04; NCGC00015004-05; NCGC00015004-06; NCGC00015004-07; NCGC00015004-08; NCGC00015004-10; NCGC00015004-11; NCGC00015004-13; NCGC00015004-16; NCGC00015004-22; NCGC00023887-03; NCGC00023887-04; NCGC00023887-05; NCGC00023887-06; NCGC00255124-01; NCGC00260801-01; BA164170; SY052450; SBI-0050104.P003; A2499; A5059; EU-0100116; NS00010454; D00228; EN300-123014; Q58356; AB00052421-13; AB00052421_14; AB00052421_15; L001293; SR-01000003001-2; SR-01000003001-4; SR-01000003001-6; BRD-K02265150-001-05-9; BRD-K02265150-001-15-8; BRD-K02265150-001-25-7; BRD-K02265150-001-26-5; BRD-K02265150-001-27-3; 2-Chloro-11-(1-piperazinyl)dibenz[b,f]-1,4-oxazepine; 2-Chloro-11-(1-piperazinyl)dibenz[b.f][1,4]oxazepine; 2-Chloro-11-(1-piperazinyl)dibenzo[b,f]-1,4-oxazepine; 2-Chloro-11-piperazin-1-yl-dibenzo[b,f][1,4]oxazepine; 2-Chloro-11-(1-piperazinyl)dibenzo[b,f][1,4]oxazepine #; (E)-2-chloro-11-(piperazin-1-yl)dibenzo[b,f][1,4]oxazepine; Amoxapine, 1.0 mg/mL in methanol, certified reference material; Amoxapine, United States Pharmacopeia (USP) Reference Standard; Dibenzo[b,f][1,4]oxazepine, 2-chloro-11-(1-piperazinyl)-; LOXAPINE SUCCINATE IMPURITY, AMOXAPINE- [USP IMPURITY]; Amoxapine, Pharmaceutical Secondary Standard; Certified Reference Material; 13-chloro-10-(piperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaene; 13-chloro-10-(piperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,9,12,14-heptaeneSynonyme
